Internal Medicine, Hematology & Oncology · Collierville, TN
NPI
1174539159
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
1500 W Poplar Ave Ste 308
Collierville, TN, 38017
Phone (901) 861-8550
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
57,523 services
Medicare patients, 2024
826
Average age 76
Drug cost, 2024
$4.0M
1,765 prescriptions
Company payments, 2025
$2,215
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward S Muir was code 85025 (blood count), 1,831 times for 744 patients. In total Edward S Muir billed 57,523 services in 108 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 1,831 | 744 | $7.57 | $14K |
| 36415 Venipuncture Blood Collection | Office | 1,809 | 747 | $8.57 | $16K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,700 | 14 | $0.09 | $149 |
| J0897 Injection, denosumab, 1 mg | Office | 1,560 | 14 | $20.32 | $32K |
| 99214 Office E&M - Established | Office | 1,530 | 718 | $83.74 | $128K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,201 | 695 | $11.20 | $13K |
| J1750 Injection, iron dextran, 50 mg | Office | 1,074 | 37 | $12.96 | $14K |
| 80053 Clinical Chemistry | Office | 653 | 467 | $10.22 | $6,675 |
| 85610 Clinical Chemistry | Office | 591 | 71 | $4.20 | $2,482 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 480 | 11 | $0.09 | $41.94 |
| 99232 Hospital E&M - Subsequent | Facility | 454 | 61 | $57.74 | $26K |
| 96372 Injection Administration | Office | 352 | 65 | $9.41 | $3,311 |
| 82728 Clinical Chemistry | Office | 261 | 214 | $12.96 | $3,383 |
| 83540 Clinical Chemistry | Office | 260 | 213 | $6.15 | $1,598 |
| 83550 Clinical Chemistry | Office | 249 | 208 | $8.33 | $2,073 |
By year: 2022 $653K for 43,212 services; 2023 $1.1M for 87,510 services; 2024 $1.1M for 57,523 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,831 | 744 | $7.57 | $14K |
| 36415 Venipuncture Blood Collection | 1,809 | 747 | $8.57 | $16K |
| 80053 Clinical Chemistry | 653 | 467 | $10.22 | $6,675 |
| 85610 Clinical Chemistry | 591 | 71 | $4.20 | $2,482 |
| 82728 Clinical Chemistry | 261 | 214 | $12.96 | $3,383 |
| 83540 Clinical Chemistry | 260 | 213 | $6.15 | $1,598 |
| 83550 Clinical Chemistry | 249 | 208 | $8.33 | $2,073 |
| 82607 Clinical Chemistry | 107 | 103 | $14.22 | $1,522 |
| 82746 Clinical Chemistry | 71 | 70 | $13.93 | $989 |
| 83615 Clinical Chemistry | 45 | 38 | $5.79 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug Edward S Muir prescribed most often to Medicare patients was Warfarin Sodium, with 356 prescriptions and refills. In total Edward S Muir wrote 1,765 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Warfarin Sodium Generic | 356 | 731 | 62 | $3,860 |
| Xarelto Rivaroxaban | 323 | 535 | 72 | $297K |
| Eliquis Apixaban | 228 | 326 | 51 | $166K |
| Clopidogrel Clopidogrel Bisulfate | 70 | 177 | 24 | $807 |
| Jakafi Ruxolitinib Phosphate | 49 | 49 | Under 11 | $853K |
| Acyclovir Generic | 47 | 57 | Under 11 | $780 |
| Hydroxyurea Generic | 42 | 82 | 12 | $739 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 39 | 75 | 14 | $628 |
| Dabigatran Etexilate Dabigatran Etexilate Mesylate | 29 | 42 | Under 11 | $6,039 |
| Dexamethasone Generic | 26 | 28 | Under 11 | $328 |
| Imbruvica Ibrutinib | 25 | 25 | Under 11 | $430K |
| Valacyclovir Valacyclovir Hcl | 25 | 31 | Under 11 | $852 |
| Gabapentin Generic | 24 | 34 | Under 11 | $329 |
| Ondansetron Odt Ondansetron | 20 | 22 | Under 11 | $362 |
| Lenalidomide Generic | 19 | 19 | Under 11 | $272K |
Brand drugs: - claims; generic drugs: 968 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward S Muir $2,215 ($2,215 in general payments such as food, travel and fees) from 34 companies. The largest payer was Janssen Biotech, Inc. with $225.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 6 | $225 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $196 |
| Pfizer Inc. PFE | 7 | $165 |
| Celgene Corporation BMY | 6 | $150 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $132 |
| Daiichi Sankyo Inc. 4568.T | 5 | $130 |
| Incyte Corporation INCY | 5 | $111 |
| GlaxoSmithKline, LLC. GSK | 5 | $102 |
| Genzyme Corporation SNY | 3 | $88.22 |
| Abbvie Inc. ABBV | 4 | $80.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.